181 related articles for article (PubMed ID: 24312582)
21. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
[TBL] [Abstract][Full Text] [Related]
22. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: A retrospective cohort study based on the Japanese Breast Cancer Registry.
Yamada A; Hayashi N; Kumamaru H; Nagahashi M; Usune S; Asaga S; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Ogo E; Tamura K; Tanakura K; Tada K; Niikura N; Yoshida M; Ohno S; Ishikawa T; Narui K; Endo I; Imoto S; Jinno H
Eur J Cancer; 2022 Sep; 172():31-40. PubMed ID: 35752154
[TBL] [Abstract][Full Text] [Related]
24. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
25. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
26. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.
Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896
[TBL] [Abstract][Full Text] [Related]
27. Can a subgroup at high risk for LRR be identified from T1-2 breast cancer with negative lymph nodes after mastectomy? A meta-analysis.
Peng G; Zhou Z; Jiang M; Yang F
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31484798
[No Abstract] [Full Text] [Related]
28. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer.
Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB
Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878
[No Abstract] [Full Text] [Related]
29. Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
Wang X; Zhang L; Zhang X; Luo J; Wang X; Chen X; Yang Z; Mei X; Yu X; Zhang Z; Guo X; Shao Z; Ma J
Breast Cancer Res Treat; 2021 Nov; 190(2):277-286. PubMed ID: 34490502
[TBL] [Abstract][Full Text] [Related]
30. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma.
Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J
Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122
[TBL] [Abstract][Full Text] [Related]
31. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
[TBL] [Abstract][Full Text] [Related]
32. Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes.
Jia MM; Liang ZJ; Chen Q; Zheng Y; Li LM; Cao XC
Cancer Biol Med; 2014 Jun; 11(2):123-9. PubMed ID: 25009754
[TBL] [Abstract][Full Text] [Related]
33. Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy?
Cosar R; Uzal C; Tokatli F; Denizli B; Saynak M; Turan N; Uzunoglu S; Ozen A; Sezer A; Ibis K; Uregen B; Yurut-Caloglu V; Kocak Z
Radiat Oncol; 2011 Mar; 6():28. PubMed ID: 21450076
[TBL] [Abstract][Full Text] [Related]
34. Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23).
Park HJ; Shin KH; Kim JH; Ahn SD; Kim JY; Park W; Kim YB; Kim YJ; Kim JH; Kim K; Park KR; Shin HS; Jeong BK; Lee SY; Kim S
Cancer Res Treat; 2017 Jul; 49(3):739-747. PubMed ID: 27764904
[TBL] [Abstract][Full Text] [Related]
35. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
[TBL] [Abstract][Full Text] [Related]
36. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
37. The effect of postmastectomy radiation therapy on high-risk patients with T1-2N0 breast cancer.
Luo C; Zhong X; Fan Y; Wang C; Wang Y; Luo T
Breast; 2021 Dec; 60():1-5. PubMed ID: 34455226
[TBL] [Abstract][Full Text] [Related]
38. The Cambridge post-mastectomy radiotherapy (C-PMRT) index: a practical tool for patient selection.
Mukesh MB; Duke S; Parashar D; Wishart G; Coles CE; Wilson C
Radiother Oncol; 2014 Mar; 110(3):461-6. PubMed ID: 24424386
[TBL] [Abstract][Full Text] [Related]
39. A multi-institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1-2N1 breast cancer.
Sittenfeld SMC; Zabor EC; Hamilton SN; Kuerer HM; El-Tamer M; Naoum GE; Truong PT; Nichol A; Smith BD; Woodward WA; Moo TA; Powell SN; Shah CS; Taghian AG; Abu-Gheida I; Tendulkar RD
Cancer; 2022 Aug; 128(16):3057-3066. PubMed ID: 35713598
[TBL] [Abstract][Full Text] [Related]
40. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer.
Lee JC; Truong PT; Kader HA; Speers CH; Olivotto IA
Clin Oncol (R Coll Radiol); 2005 Dec; 17(8):623-9. PubMed ID: 16372488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
